UK markets closed
  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     
  • FTSE 250

    22,883.39
    +206.11 (+0.91%)
     
  • AIM

    1,232.54
    +4.45 (+0.36%)
     
  • GBP/EUR

    1.1675
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.3754
    -0.0013 (-0.10%)
     
  • BTC-GBP

    24,897.54
    -253.42 (-1.01%)
     
  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     
  • S&P 500

    4,411.79
    +44.31 (+1.01%)
     
  • DOW

    35,061.55
    +238.20 (+0.68%)
     
  • CRUDE OIL

    72.17
    +0.26 (+0.36%)
     
  • GOLD FUTURES

    1,802.10
    -3.30 (-0.18%)
     
  • NIKKEI 225

    27,548.00
    +159.80 (+0.58%)
     
  • HANG SENG

    27,321.98
    -401.86 (-1.45%)
     
  • DAX

    15,669.29
    +154.75 (+1.00%)
     
  • CAC 40

    6,568.82
    +87.23 (+1.35%)
     

Global Central Venous Catheters (CVCs) Market to Reach US$1.6 Billion by the Year 2027

·24-min read

Abstract: - Global Central Venous Catheters (CVCs) Market to Reach US$1. 6 Billion by the Year 2027. - Amid the COVID-19 crisis, the global market for Central Venous Catheters (CVCs) estimated at US$1.

New York, June 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Central Venous Catheters (CVCs) Industry" - https://www.reportlinker.com/p05899197/?utm_source=GNW
1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027.Multi-Lumen, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$793.9 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Triple-Lumen segment is readjusted to a revised 5.2% CAGR for the next 7-year period. This segment currently accounts for a 28.2% share of the global Central Venous Catheters (CVCs) market.

- The U.S. Accounts for Over 34.2% of Global Market Size in 2020, While China is Forecast to Grow at a 7.1% CAGR for the Period of 2020-2027

- The Central Venous Catheters (CVCs) market in the U.S. is estimated at US$388.2 Million in the year 2020. The country currently accounts for a 34.17% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$192 Million in the year 2027 trailing a CAGR of 7.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$192 Million by the year 2027.

- Double-Lumen Segment Corners a 17.7% Share in 2020

- In the global Double-Lumen segment, USA, Canada, Japan, China and Europe will drive the 4.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$159.1 Million in the year 2020 will reach a projected size of US$215.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$173 Million by the year 2027, while Latin America will expand at a 5.3% CAGR through the analysis period.

- Select Competitors (Total 61 Featured)

  • Amecath

  • AngioDynamics, Inc.

  • B. Braun Melsungen AG

  • BACTIGUARD

  • BARD, A Becton, Dickinson Company

  • Becton, Dickinson & Company

  • Biosensors International Group Ltd.

  • Boston Scientific Corporation

  • ConMed Corporation

  • Cook Medical, Inc.

  • Edwards Lifesciences Corporation

  • Guangdong Baihe Medical Technology Co., Ltd.

  • Henan Tuoren Medical Device Co., Ltd.

  • Intra Special Catheters GmbH

  • ISO-MED, INC.

  • Kimal PLC

  • Lepu Mdicial Technology (Beijing) Co., Ltd

  • Medical Components, Inc.

  • PRODIMED ZI

  • SCW Medicath Ltd.

  • SILMAG

  • Smiths Medical

  • Teleflex Inc.

  • Terumo Corporation

  • Troge Medical GmbH

  • Vogt Medical Vertrieb GmbH

  • Vygon SA

  • ZOLL Medical Corporation




Read the full report: https://www.reportlinker.com/p05899197/?utm_source=GNW

CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Pandemic Disrupts Operations of Medical Equipment and Supplies
Industry
Elective Surgeries Report Roller-Coaster Ride Amid COVID-19
EXHIBIT 2: COVID-19 Induced YOY Decline in Heart Surgery
Volumes in the US in 2020
COVID-19 Results in Colossal Backlog of Elective Surgeries &
Extended Waiting Times
Pandemic Affects Demand for Central Venous Catheters (CVCs)
Central Venous Catheters Remain Crucial Element of COVID-19
Patients? Treatment
Central Venous Catheter (CVC): An Indispensable Medical Device
for Healthcare Domain
Contradictions & Complications of CVCs
Types of Central Venous Catheters
Global Market Prospects & Outlook
EXHIBIT 3: Global Central Venous Catheters Market by Product
Type (in %) for 2020E
Multi-Lumen Design Leads the CVCs Market
Antimicrobial Coated Catheters to Witness High Growth
Hospitals: The Largest End-Use Category
Developing Economies to Spearhead Long-term Growth
Competition
World Brands
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Incidence of Chronic Diseases Necessitate Central Venous
Access, Driving Demand for CVCs
EXHIBIT 4: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 5: World Diabetes and Population Statistics (2019, 2030 &
2045)
EXHIBIT 6: ESRD Prevalence Worldwide: Number of Treated ESRD
Patients Per Million Population in Select Countries for 2019
EXHIBIT 7: Global Annual Medical Cost of CVD in US$ Billion:
2010, 2015, 2020, 2025 and 2030
Aging Population with Higher Susceptibility to Age-related
Chronic Conditions to Drive Market Gains
EXHIBIT 8: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 9: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
EXHIBIT 10: Life Expectancy at Age 60 and 80 Years: (2010-2015
), (2020-2025) & (2045-2050)
Use of Central Venous Catheterization for Chemotherapy
Administration Boosts Market Growth
Catheters Hold Vital Role in Drugs & Fluid Delivery in Cancer
Treatment
Expanding Patient Population Diagnosed with Renal Diseases:
Potential Growth for CVCs Market
EXHIBIT 11: Global Dialysis Patient Population Breakdown by
Geographic Region/Country (2019 and 2024)
Catheter-Related Infections during Hemodialysis Reduce due to
Hygiene Procedures
Percutaneous Translumbar Insertion for Alternate Venous Access
for Dialysis of COVID-19 ARDS Patients
Surgical Procedure Volumes and Shift towards Minimal Invasive
Surgeries: Significant Impact on CVCs Market
EXHIBIT 12: Global Volume of Surgical Procedures (in Million)
by Category: 2019
EXHIBIT 13: Growth in the Number of Surgeries in the US (2010-
2020) and 2001-2010 (in %)
EXHIBIT 14: Number of Surgical Procedures (per 100,000 People)
in Select Countries
Central Venous Catheters: Playing Critical Role in Parenteral
Nutrition
Growing Role of Central Venous Catheters in Drug Administration
Rising Use of Central Venous Catheters in ICU Settings
Growing Adoption of Antimicrobial Impregnated Catheters
Technologically Advanced CVCs Promise Better Outcomes for
Interventional Procedures
3M Korea?s All-in-One PICC/CVC Securing System
Clear Correlation between CVD Risk and Central Venous Catheter
Insertion Calls for Minimization of Catheter Use
Consistent Rise in Healthcare Spending Worldwide to Drive
Market Opportunities
EXHIBIT 15: World Healthcare Expenditure (In US$ Trillion) for
the Years for 2017, 2019, 2021 and 2023
EXHIBIT 16: Elderly Healthcare Expenditure as a % of GDP in the
US, Europe and Japan for 1970, 2010 and 2050
Challenges Facing Central Venous Catheters Market

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Central Venous
Catheters (CVCs) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Central Venous Catheters
(CVCs) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Central Venous Catheters
(CVCs) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Multi-Lumen by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Multi-Lumen by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Multi-Lumen by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Triple-Lumen by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Triple-Lumen by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Triple-Lumen by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Double-Lumen by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Double-Lumen by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Double-Lumen by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Single-Lumen by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Single-Lumen by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Single-Lumen by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Non-Antimicrobial
Coated by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Non-Antimicrobial Coated by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Non-Antimicrobial
Coated by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 19: World Current & Future Analysis for Antimicrobial
Coated by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Antimicrobial Coated by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Antimicrobial Coated by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Jugular Vein by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Jugular Vein by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Jugular Vein by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Femoral Vein by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Femoral Vein by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Femoral Vein by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Subclavian Vein
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Subclavian Vein by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Subclavian Vein by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 35: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 37: USA Current & Future Analysis for Central Venous
Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen,
Double-Lumen and Single-Lumen - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 38: USA Historic Review for Central Venous Catheters
(CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Central Venous Catheters
(CVCs) by Design - Percentage Breakdown of Value Sales for
Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for
the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Central Venous
Catheters (CVCs) by Property - Non-Antimicrobial Coated and
Antimicrobial Coated - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Central Venous Catheters
(CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial
Coated Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Central Venous Catheters
(CVCs) by Property - Percentage Breakdown of Value Sales for
Non-Antimicrobial Coated and Antimicrobial Coated for the Years
2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Central Venous
Catheters (CVCs) by Application - Jugular Vein, Femoral Vein
and Subclavian Vein - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for Central Venous Catheters
(CVCs) by Application - Jugular Vein, Femoral Vein and
Subclavian Vein Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for Central Venous Catheters
(CVCs) by Application - Percentage Breakdown of Value Sales for
Jugular Vein, Femoral Vein and Subclavian Vein for the Years
2012, 2020 & 2027

Table 46: USA Current & Future Analysis for Central Venous
Catheters (CVCs) by End-Use - Hospitals and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: USA Historic Review for Central Venous Catheters
(CVCs) by End-Use - Hospitals and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: USA 15-Year Perspective for Central Venous Catheters
(CVCs) by End-Use - Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 49: Canada Current & Future Analysis for Central Venous
Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen,
Double-Lumen and Single-Lumen - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 50: Canada Historic Review for Central Venous Catheters
(CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Central Venous
Catheters (CVCs) by Design - Percentage Breakdown of Value
Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen for the Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Central Venous
Catheters (CVCs) by Property - Non-Antimicrobial Coated and
Antimicrobial Coated - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Canada Historic Review for Central Venous Catheters
(CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial
Coated Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Central Venous
Catheters (CVCs) by Property - Percentage Breakdown of Value
Sales for Non-Antimicrobial Coated and Antimicrobial Coated for
the Years 2012, 2020 & 2027

Table 55: Canada Current & Future Analysis for Central Venous
Catheters (CVCs) by Application - Jugular Vein, Femoral Vein
and Subclavian Vein - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Canada Historic Review for Central Venous Catheters
(CVCs) by Application - Jugular Vein, Femoral Vein and
Subclavian Vein Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 57: Canada 15-Year Perspective for Central Venous
Catheters (CVCs) by Application - Percentage Breakdown of Value
Sales for Jugular Vein, Femoral Vein and Subclavian Vein for
the Years 2012, 2020 & 2027

Table 58: Canada Current & Future Analysis for Central Venous
Catheters (CVCs) by End-Use - Hospitals and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Canada Historic Review for Central Venous Catheters
(CVCs) by End-Use - Hospitals and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 60: Canada 15-Year Perspective for Central Venous
Catheters (CVCs) by End-Use - Percentage Breakdown of Value
Sales for Hospitals and Other End-Uses for the Years 2012, 2020 &
2027

JAPAN
Table 61: Japan Current & Future Analysis for Central Venous
Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen,
Double-Lumen and Single-Lumen - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 62: Japan Historic Review for Central Venous Catheters
(CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: Japan 15-Year Perspective for Central Venous
Catheters (CVCs) by Design - Percentage Breakdown of Value
Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen for the Years 2012, 2020 & 2027

Table 64: Japan Current & Future Analysis for Central Venous
Catheters (CVCs) by Property - Non-Antimicrobial Coated and
Antimicrobial Coated - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Japan Historic Review for Central Venous Catheters
(CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial
Coated Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 66: Japan 15-Year Perspective for Central Venous
Catheters (CVCs) by Property - Percentage Breakdown of Value
Sales for Non-Antimicrobial Coated and Antimicrobial Coated for
the Years 2012, 2020 & 2027

Table 67: Japan Current & Future Analysis for Central Venous
Catheters (CVCs) by Application - Jugular Vein, Femoral Vein
and Subclavian Vein - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Japan Historic Review for Central Venous Catheters
(CVCs) by Application - Jugular Vein, Femoral Vein and
Subclavian Vein Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Japan 15-Year Perspective for Central Venous
Catheters (CVCs) by Application - Percentage Breakdown of Value
Sales for Jugular Vein, Femoral Vein and Subclavian Vein for
the Years 2012, 2020 & 2027

Table 70: Japan Current & Future Analysis for Central Venous
Catheters (CVCs) by End-Use - Hospitals and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Japan Historic Review for Central Venous Catheters
(CVCs) by End-Use - Hospitals and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 72: Japan 15-Year Perspective for Central Venous
Catheters (CVCs) by End-Use - Percentage Breakdown of Value
Sales for Hospitals and Other End-Uses for the Years 2012, 2020 &
2027

CHINA
Table 73: China Current & Future Analysis for Central Venous
Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen,
Double-Lumen and Single-Lumen - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 74: China Historic Review for Central Venous Catheters
(CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: China 15-Year Perspective for Central Venous
Catheters (CVCs) by Design - Percentage Breakdown of Value
Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen for the Years 2012, 2020 & 2027

Table 76: China Current & Future Analysis for Central Venous
Catheters (CVCs) by Property - Non-Antimicrobial Coated and
Antimicrobial Coated - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 77: China Historic Review for Central Venous Catheters
(CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial
Coated Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 78: China 15-Year Perspective for Central Venous
Catheters (CVCs) by Property - Percentage Breakdown of Value
Sales for Non-Antimicrobial Coated and Antimicrobial Coated for
the Years 2012, 2020 & 2027

Table 79: China Current & Future Analysis for Central Venous
Catheters (CVCs) by Application - Jugular Vein, Femoral Vein
and Subclavian Vein - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 80: China Historic Review for Central Venous Catheters
(CVCs) by Application - Jugular Vein, Femoral Vein and
Subclavian Vein Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: China 15-Year Perspective for Central Venous
Catheters (CVCs) by Application - Percentage Breakdown of Value
Sales for Jugular Vein, Femoral Vein and Subclavian Vein for
the Years 2012, 2020 & 2027

Table 82: China Current & Future Analysis for Central Venous
Catheters (CVCs) by End-Use - Hospitals and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: China Historic Review for Central Venous Catheters
(CVCs) by End-Use - Hospitals and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 84: China 15-Year Perspective for Central Venous
Catheters (CVCs) by End-Use - Percentage Breakdown of Value
Sales for Hospitals and Other End-Uses for the Years 2012, 2020 &
2027

EUROPE
Table 85: Europe Current & Future Analysis for Central Venous
Catheters (CVCs) by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 86: Europe Historic Review for Central Venous Catheters
(CVCs) by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 87: Europe 15-Year Perspective for Central Venous
Catheters (CVCs) by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 88: Europe Current & Future Analysis for Central Venous
Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen,
Double-Lumen and Single-Lumen - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 89: Europe Historic Review for Central Venous Catheters
(CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Europe 15-Year Perspective for Central Venous
Catheters (CVCs) by Design - Percentage Breakdown of Value
Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen for the Years 2012, 2020 & 2027

Table 91: Europe Current & Future Analysis for Central Venous
Catheters (CVCs) by Property - Non-Antimicrobial Coated and
Antimicrobial Coated - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 92: Europe Historic Review for Central Venous Catheters
(CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial
Coated Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 93: Europe 15-Year Perspective for Central Venous
Catheters (CVCs) by Property - Percentage Breakdown of Value
Sales for Non-Antimicrobial Coated and Antimicrobial Coated for
the Years 2012, 2020 & 2027

Table 94: Europe Current & Future Analysis for Central Venous
Catheters (CVCs) by Application - Jugular Vein, Femoral Vein
and Subclavian Vein - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Europe Historic Review for Central Venous Catheters
(CVCs) by Application - Jugular Vein, Femoral Vein and
Subclavian Vein Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 96: Europe 15-Year Perspective for Central Venous
Catheters (CVCs) by Application - Percentage Breakdown of Value
Sales for Jugular Vein, Femoral Vein and Subclavian Vein for
the Years 2012, 2020 & 2027

Table 97: Europe Current & Future Analysis for Central Venous
Catheters (CVCs) by End-Use - Hospitals and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Europe Historic Review for Central Venous Catheters
(CVCs) by End-Use - Hospitals and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 99: Europe 15-Year Perspective for Central Venous
Catheters (CVCs) by End-Use - Percentage Breakdown of Value
Sales for Hospitals and Other End-Uses for the Years 2012, 2020 &
2027

FRANCE
Table 100: France Current & Future Analysis for Central Venous
Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen,
Double-Lumen and Single-Lumen - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 101: France Historic Review for Central Venous Catheters
(CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and
Single-Lumen Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: France 15-Year Perspective for Central Venous
Catheters (CVCs) by Design - Percentage Breakdown of Value
Sales for Multi-Lumen, Triple-Lumen,
Read the full report: https://www.reportlinker.com/p05899197/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting